CDC Director Dr. Rochelle Walensky signed off on a series of recommendations from a panel of advisers late Thursday, but she also included one recommendation that the panel had rejected.
Advisers to the Centers for Disease Control and Prevention said boosters should be offered to people 65 and older, nursing home residents and those ages 50 to 64 who have risky underlying health problems.
In 2011, Khan started the nation’s first post-ICU outpatient clinic, specifically to address the physical and mental deficits often experienced by ICU patients.
They moved back to their hometown of Indianapolis in 2014 and immediately got involved with local Alzheimer’s organizations, including the Alzheimer’s Association’s central Indiana chapter.
The average person doesn’t need a COVID-19 booster yet, an international group of scientists—including two top U.S. regulators—wrote Monday in a scientific journal.
Three major studies published Friday by the Centers for Disease Control and Prevention highlight the continued efficacy of all three vaccines amid the spread of the highly contagious delta variant.
The engine maker confirmed Wednesday it is pushing its return-to-office timeline to early next year as COVID-19 infections and hospitalizations surge in Indiana and the nation.
President Joe Biden’s plans to start delivery of booster shots by Sept. 20 for most Americans who received the COVID-19 vaccines are facing new complications that could delay the availability of third doses for those who received the Moderna vaccine, administration officials said Friday.
According to a report by the Indiana Economic Development Corp., the Hoosier state ranks second nationally for worldwide life sciences exports and among the top five states for life sciences industry jobs.
Roche Diagnostics is requiring COVID-19 vaccinations for all 8,000 people in its U.S. workforce, including about 4,500 in Indianapolis. Employees will have until Nov. 15 to get fully vaccinated, or will be terminated, the company said in a statement.
The sectors in central Indiana account for one out of every 10 jobs here, or 164,144 workers, and the jobs pay an average of $77,229, according to the report commissioned by BioCrossroads.
A flurry of private and public employers are requiring workers to get vaccinated against COVID-19 after the federal government gave full approval to the Pfizer shot. And the number is certain to grow much higher.
As COVID-19 surged last year, governments worldwide touted the hope of “herd immunity,” a promised land where the virus stopped spreading exponentially because enough people were protected against it. That’s now looking like a fantasy.
The vaccination news comes as the nation continues to experience an increase in coronavirus cases, hospitalizations and deaths. Ninety percent of U.S. counties are now experiencing substantial or high transmission of the virus.
Friday’s report from the Centers for Disease Control and Prevention adds to growing laboratory evidence that people who had one bout of COVID-19 get a dramatic boost in virus-fighting immune cells—and a bonus of broader protection against new mutants—when they’re vaccinated.
Yadav runs Indianapolis-based Quest Safety Products, which managed to grow sales 62% last year despite the wrench the pandemic threw into the global economy. Now, the company is investing $5.5 million in a 58,000-square-foot facility in the Park Fletcher area.
Marion County Public Health Department officials also suggested a set of yes-or-no questions that could help residents decide when masking is appropriate, regardless of vaccination status.
Citing new information about the ability of the delta variant to spread among vaccinated people, the CDC also recommended indoor masks for all teachers, staff, students and visitors to schools, regardless of vaccination status.
Prominent businesses such as Eli Lilly and Co., Cummins Inc., Roche Diagnostics and Salesforce are among the Indiana companies that signed the letter urging passage of the Equality Act.
What’s more, 64% of unvaccinated Americans have little to no confidence the shots are effective against variants—including the delta variant that officials say is responsible for 83% of new cases in the U.S.—despite evidence that they offer strong protection.
